Grand Pharmaceutical Group Limited MX6A.F Stock
Grand Pharmaceutical Group Limited Price Chart
Grand Pharmaceutical Group Limited MX6A.F Financial and Trading Overview
| Grand Pharmaceutical Group Limited stock price | 0.48 EUR |
| Previous Close | 0.53 EUR |
| Open | 0.53 EUR |
| Bid | 0.53 EUR x N/A |
| Ask | 0.54 EUR x N/A |
| Day's Range | 0.53 - 0.53 EUR |
| 52 Week Range | 0.41 - 0.6 EUR |
| Volume | 182 EUR |
| Avg. Volume | 3 EUR |
| Market Cap | 1.9B EUR |
| Beta (5Y Monthly) | 0.939463 |
| PE Ratio (TTM) | 7.5714283 |
| EPS (TTM) | 0.06 EUR |
| Forward Dividend & Yield | 0.02 (3.13%) |
| Ex-Dividend Date | June 9, 2023 |
| 1y Target Est | N/A |
MX6A.F Valuation Measures
| Enterprise Value | 3.09B EUR |
| Trailing P/E | 7.5714283 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.19831672 |
| Price/Book (mrq) | 0.1319064 |
| Enterprise Value/Revenue | 0.323 |
| Enterprise Value/EBITDA | 0.929 |
Trading Information
Grand Pharmaceutical Group Limited Stock Price History
| Beta (5Y Monthly) | 0.939463 |
| 52-Week Change | 1.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.6 EUR |
| 52 Week Low | 0.41 EUR |
| 50-Day Moving Average | 0.56 EUR |
| 200-Day Moving Average | 0.51 EUR |
MX6A.F Share Statistics
| Avg. Volume (3 month) | 3 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 3.55B |
| Float | 1.16B |
| Short Ratio | N/A |
| % Held by Insiders | 61.53% |
| % Held by Institutions | 14.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.14 |
| Trailing Annual Dividend Yield | 26.66% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1874 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 21.74% |
| Operating Margin (ttm) | 31.01% |
| Gross Margin | 62.23% |
| EBITDA Margin | 34.79% |
Management Effectiveness
| Return on Assets (ttm) | 8.53% |
| Return on Equity (ttm) | 15.17% |
Income Statement
| Revenue (ttm) | 9.56B EUR |
| Revenue Per Share (ttm) | 2.7 EUR |
| Quarterly Revenue Growth (yoy) | 7.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 3.33B EUR |
| Net Income Avi to Common (ttm) | 2.08B EUR |
| Diluted EPS (ttm) | 0.07 |
| Quarterly Earnings Growth (yoy) | 14.09% |
Balance Sheet
| Total Cash (mrq) | 3.31B EUR |
| Total Cash Per Share (mrq) | 0.94 EUR |
| Total Debt (mrq) | 4.5B EUR |
| Total Debt/Equity (mrq) | 31.67 EUR |
| Current Ratio (mrq) | 1.067 |
| Book Value Per Share (mrq) | 4.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.84B EUR |
| Levered Free Cash Flow (ttm) | 547.59M EUR |
Profile of Grand Pharmaceutical Group Limited
| Country | Germany |
| State | N/A |
| City | Central |
| Address | The Center |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.grandpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10172 |
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It also manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.
Q&A For Grand Pharmaceutical Group Limited Stock
What is a current MX6A.F stock price?
Grand Pharmaceutical Group Limited MX6A.F stock price today per share is 0.48 EUR.
How to purchase Grand Pharmaceutical Group Limited stock?
You can buy MX6A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Grand Pharmaceutical Group Limited?
The stock symbol or ticker of Grand Pharmaceutical Group Limited is MX6A.F.
Which industry does the Grand Pharmaceutical Group Limited company belong to?
The Grand Pharmaceutical Group Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Grand Pharmaceutical Group Limited have in circulation?
The max supply of Grand Pharmaceutical Group Limited shares is 3.53B.
What is Grand Pharmaceutical Group Limited Price to Earnings Ratio (PE Ratio)?
Grand Pharmaceutical Group Limited PE Ratio is 8.06666700 now.
What was Grand Pharmaceutical Group Limited earnings per share over the trailing 12 months (TTM)?
Grand Pharmaceutical Group Limited EPS is 0.06 EUR over the trailing 12 months.
Which sector does the Grand Pharmaceutical Group Limited company belong to?
The Grand Pharmaceutical Group Limited sector is Healthcare.